Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript

LP-300 shows strong efficacy in lung cancer while operating losses shrink 25%.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at fool.com →

More in Finance & Markets

Wall Street Set To Bounce Back

(RTTNews) - Initial cues from the U.S. Futures Index suggest that Wall Street might open significantly higher on Friday, while the major averages finished lower at yesterday's close.

More from Friday 21 August →